EQS Voting Rights Announcement: Kontron AG Kontron AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution 12.03.2026 / 19:00 CET/CEST Dissemination of a ...
On 11 March 2026, the Slovak news outlet Denník N published an article concerning the alleged efforts of the Slovak government to secure the removal of two Russian nationals from the ...
The introduction of its second 'payment intelligence' product comes as merchants facing economic headwinds look for ways to address lost revenue GoCardless, a global leader in bank payment solutions, ...
Taking another step forward in a trend that has been transforming the shipping industry, Leschaco, a global logistics service provider with more than 140 years of experience, has decided to digitize ...
of 3% and on that day amounted to 2.998% (equivalent to 5,622,022 shares).
A research group at the Medical University of Graz has found evidence suggesting that chronic stress and worry in the period before contracting COVID-19 increase the probability of developing long ...
BMO Financial Group will announce its fourth quarter and fiscal 2021 financial results and hold its investor community conference call on December 3, 2021. Financial results will be issued in a news ...
Grünenthal, a global leader in pain management and related diseases, and BCWorld Pharm Co., Ltd. ("BCWP"), a specialty company actively expanding and ...
EQS-News: Flughafen Wien AG 2025: Good business development and revenue increase of 7.2% - Net earnings of € 210.1 million impacted by derecognition of assets – Dividend of € 1.65 at the prior-year ...
EQS-News: AT&S Austria Technologie & Systemtechnik AG / Key word(s): Quarter Results AT&S records slight upward trend in the first quarter 01.08.2024 / 07:00 CET/CEST The issuer is solely responsible ...
OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | ...
Grünenthal acquired Kyowa Kirin International's 49% stake in 'Grünenthal Meds', a joint venture formed in 2023 to market the established medicines portfolio from Kyowa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results